Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 219

    2.

    Contribution of fasting and postprandial hyperglycemia to hemoglobin A1c in insulin-treated Japanese diabetic patients.

    Shimizu H, Uehara Y, Okada S, Mori M.

    Endocr J. 2008 Aug;55(4):753-6. Epub 2008 May 23.PMID: 18497454 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Morning hyperglycemic excursions: a constant failure in the metabolic control of non-insulin-using patients with type 2 diabetes.

    Monnier L, Colette C, Rabasa-Lhoret R, Lapinski H, Caubel C, Avignon A, Boniface H.

    Diabetes Care. 2002 Apr;25(4):737-41.PMID: 11919134 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A simple way to estimate mean plasma glucose and to identify Type 2 diabetic subjects with poor glycaemic control when a standardized HbA1c assay is not available.

    Ozmen S, Cil T, Atay AE, Tuzcu AK, Bahceci M.

    Diabet Med. 2006 Oct;23(10):1151-4.PMID: 16978383 [PubMed - indexed for MEDLINE]Related articles

    6.

    Relationship between diurnal glucose levels and HbA1c in type 2 diabetes.

    Pistrosch F, Koehler C, Wildbrett J, Hanefeld M.

    Horm Metab Res. 2006 Jul;38(7):455-9.PMID: 16933182 [PubMed - indexed for MEDLINE]Related articles

    7.

    [The features of postprandial glucose state in type 2 diabetes mellitus]

    Zhou J, Jia WP, Yu M, Ma XJ, Bao YQ, Lu W.

    Zhonghua Yi Xue Za Zhi. 2006 Apr 11;86(14):970-5. Chinese. PMID: 16759538 [PubMed - indexed for MEDLINE]Related articles

    8.

    Targeting prandial hyperglycemia: how important is it and how best to do this?

    Monnier L, Colette C.

    Curr Diab Rep. 2008 Oct;8(5):368-74.PMID: 18778585 [PubMed - indexed for MEDLINE]Related articles

    9.

    Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.

    Fonseca V, Grunberger G, Gupta S, Shen S, Foley JE.

    Diabetes Care. 2003 Jun;26(6):1685-90.PMID: 12766094 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

    Monnier L, Colette C, Dunseath GJ, Owens DR.

    Diabetes Care. 2007 Feb;30(2):263-9.PMID: 17259492 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Postprandial glucose regulation: new data and new implications.

    Leiter LA, Ceriello A, Davidson JA, Hanefeld M, Monnier L, Owens DR, Tajima N, Tuomilehto J; International Prandial Glucose Regulation Study Group.

    Clin Ther. 2005;27 Suppl B:S42-56. Review.PMID: 16519037 [PubMed - indexed for MEDLINE]Related articles

    12.

    Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.

    Henkel E, Menschikowski M, Koehler C, Leonhardt W, Hanefeld M.

    Metabolism. 2005 Sep;54(9):1168-73.PMID: 16125528 [PubMed - indexed for MEDLINE]Related articles

    13.

    Plasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic control.

    Bonora E, Calcaterra F, Lombardi S, Bonfante N, Formentini G, Bonadonna RC, Muggeo M.

    Diabetes Care. 2001 Dec;24(12):2023-9.PMID: 11723077 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels.

    Woerle HJ, Neumann C, Zschau S, Tenner S, Irsigler A, Schirra J, Gerich JE, Göke B.

    Diabetes Res Clin Pract. 2007 Aug;77(2):280-5. Epub 2007 Jan 22.PMID: 17240473 [PubMed - indexed for MEDLINE]Related articles

    15.

    Differential effect of pioglitazone (PGZ) and rosiglitazone (RGZ) on postprandial glucose and lipid metabolism in patients with type 2 diabetes mellitus: a prospective, randomized crossover study.

    Chappuis B, Braun M, Stettler C, Allemann S, Diem P, Lumb PJ, Wierzbicki AS, James R, Christ ER.

    Diabetes Metab Res Rev. 2007 Jul;23(5):392-9.PMID: 17211855 [PubMed - indexed for MEDLINE]Related articles

    16.

    Defining the role of insulin lispro in the management of postprandial hyperglycaemia in patients with type 2 diabetes mellitus.

    Giugliano D, Ceriello A, Razzoli E, Esposito K.

    Clin Drug Investig. 2008;28(4):199-210. Review.PMID: 18345710 [PubMed - indexed for MEDLINE]Related articles

    17.

    Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

    Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

    Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Postprandial plasma glucose: a good index of glycemic control in type 2 diabetic patients having near-normal fasting glucose levels.

    Soonthornpun S, Rattarasarn C, Leelawattana R, Setasuban W.

    Diabetes Res Clin Pract. 1999 Oct;46(1):23-7.PMID: 10580612 [PubMed - indexed for MEDLINE]Related articles

    19.

    Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

    Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C.

    JAMA. 2006 Apr 12;295(14):1681-7.PMID: 16609090 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements.

    Dailey G.

    Mayo Clin Proc. 2007 Feb;82(2):229-35; quiz 236. Review.PMID: 17290732 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data